A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Clinical trial NCT06383273 · RECRUITING
Trial details
- NCT number
- NCT06383273
- Sponsor
- Melt Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2024-12-01
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.